APP and Alzheimer disease: In both the contextual test on the second day of CFC and the cued test on the third day of CFC, the freezing time of P2Y1-shRNA-treated AD mice was higher than that of APP/PS1 mice, and the freezing time of mice in the WT group was the longest (Fig. 9, B-E).